Converge Bio raised 25 million dollars in Series A funding led by Bessemer, bringing its total finan...
The AMW Read
Updates the player map for the Vertical AI — Healthcare/Bio segment with a successful Series A for a protein manufacturing/antibody discovery platform.
NoveltySignificance
Healthcare & Bio · Player Map
Converge Bio raised 25 million dollars in Series A funding led by Bessemer, bringing its total financing to 30 million dollars. 🚀 The platform has completed 40 programs, achieving 4 to 7 times higher protein manufacturing yields and discovering antibodies with single-digit nanomolar binding affinities. By integrating multiple models into a single system, they allow biologists to work without writing code. 🧬 This shift from trial-and-error to high-velocity AI systems represents a systemic leap for oncology and neurodegenerative R&D. 🔬
